Open Public Meeting

Per CMS Internet Only Manual (IOM), Publication 100-08, Medicare Program Integrity Manual, Chapter 13.2.4.4, "After the proposed LCD is made public, MACs shall hold open meetings to discuss the review of the evidence and the rationale for the proposed LCD(s) with stakeholders in their jurisdiction."

An Open Meeting is scheduled by the Medical Director(s) after a proposed LCD is posted. The open meeting takes place during the 45-day comment period.

This meeting is for the oral presentation of comments and for stakeholders interested in listening to the comments. For oral comments to be included in the review and consideration of the proposed LCD, these comments must also be submitted in writing through the formal comment process during the comment period.

Registration

Registration is required for those that wish to present comments, and registration is encouraged for those that wish to listen to the meeting. To register for an Open Meeting, please use the link found in the "Upcoming Meetings" table below.

If you are submitting a presentation, all final presentations must be submitted to openmeeting@noridian.com by the due date listed below.

State Date Time In Person Location Teleconference Agenda Topics Presentations Due
All 04/30/26 2 - 4 p.m. CT Teleconference Only 04/23/26

Previous Meeting Documents and Recordings

State Date Agenda Topics Recordings
All 02/12/26
  • Allergy Diagnostic Testing
  • Agenda
Recording and Transcript
All 10/30/25
  • Peripheral Nerve Blocks and Procedures for Chronic Pain
  • Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices
  • Agenda
Recording and Transcript
All 06/26/25
  • Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC)
  • Lab: Special Histochemical Stains and Immunohistochemical Stains
  • Transurethral Waterjet Ablation of the Prostate
  • Agenda
Recording and Transcript
All 03/06/25
  • Allergen Immunotherapy (AIT) with Subcutaneous Immunotherapy (SCIT)
  • Agenda
Recording and Transcript
All 10/07/24
  • Intervertebral Disc Repair
  • Agenda
Recording and Transcript
All 06/27/24
  • Botulinum Toxin Injections
  • Micro Invasive Glaucoma Surgery (MIGS)
  • Artificial Intelligence Enabled Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)
  • Agenda
Recording and Transcript
All 05/16/24
  • Skin Substitutes Grafts/Cellular Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers
  • Agenda
Recording and Transcript
All 04/18/24 Recording and Transcript
All 02/15/24
  • Cervical Fusion
  • Facet Joint Interventions for Pain Management
  • Agenda
Recording and Transcript
All 11/02/23
  • Implantable Continuous Glucose Monitors (I-CGM)
  • Agenda
Recording and Transcript
All 08/31/23
  • Intraosseous Basivertebral Nerve Ablation
  • Trigger Point Injections (TPI)
  • Agenda
Recording and Transcript
All 07/13/23
  • Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
  • Transurethral Waterjet Ablation of the Prostate
  • Micro-Invasive Glaucoma Surgery (MIGS)
  • Respiratory Care
  • Agenda
Recording and Transcript
All 06/08/23 Recording and Transcript
All 03/09/23
  • Magnetic-Resonance-Guided Focused Ultrasound Surgery (MRgFUS) for Essential Tremor and Tremor Dominant Parkinson's Disease
  • Cataract Surgery in Adults
  • Transcranial Magnetic Stimulation (TMS)
  • Agenda
Recording and Transcript
All 10/27/22
  • Sacroiliac Joint Injections and Procedures
  • Agenda
Recording and Transcript
All 08/25/22
  • Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin
  • Agenda
Recording and Transcript
All 05/26/22
  • Lumbar Epidural Injections
  • MolDX: 4 KScore® Assay
  • MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
  • Nerve Blockade for Treatment of Chronic Pain and Neuropathy
  • Agenda
Recording and Transcript
All 2/24/22
  • LCD: Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
  • LCD: MolDX: Plasma-Based Genomic Profiling in Solid Tumors
  • LCD: Epidural Steroid Injections for Pain Management
  • Agenda
Recording and Transcript
All 08/31/21
  • LCD: Colon Capsule Endoscopy (CCE)
  • LCD: Epidural Procedures for Pain Management
  • Billing and Coding Article: Epidural Procedures for Pain Management
  • Agenda
Recording and Transcript
All 07/21/21
  • Platelet Rich Plasma Injections for Non-Wound Injections
  • Agenda
Recording and Transcript
All 06/03/21
  • Micro-Invasive Glaucoma Surgery (MIGS)
  • Agenda
Recording and Transcript
All 02/24/21 Recording and Transcript
All 11/05/20
  • Colon Capsule Endoscopy (CCE)
  • Agenda
Recording and Transcript
All 10/21/20
  • Facet Joint Interventions for Pain Management
  • Agenda
Recording and Transcript
All 07/15/20
  • Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia
  • Agenda
Recording and Transcript
All 07/16/20
  • Computed Tomography Cerebral Perfusion Analysis (CTP)
  • Agenda
Recording and Transcript
All 06/17/20
  • Implantable Continuous Glucose Monitor (I-CGM)
  • Agenda
Recording and Transcript
All 06/10/20
  • Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF)
  • Agenda
Recording and Transcript
All 06/10/20
  • Lab: Urine Drug Testing
  • Agenda
Recording and Transcript
All 05/20/20
  • Non-Invasive Fractional Flow Reserve (FFR) for Stable Ischemic Heart Disease
  • Agenda
Recording and Transcript
All 11/12/19
  • Non-Invasive Fractional Flow Reserve (FFR) for Stable Ischemic Heart Disease
  • Non-Invasive Fractional Flow Reserve (FFR) for Stable Ischemic Heart Disease Billing and Coding LCA
Recording and Transcript
All 09/09/19
  • Micro-Invasive Glaucoma Surgery (MIGS)
  • Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
Recording and Transcript
Last Updated Apr 14 , 2026